Global Inflammatory Bowel Disease Market Research Report 2023

Report ID: 1988390 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Inflammatory Bowel Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Aminosalicylates
        1.2.3 Antibiotics
        1.2.4 Corticosteroids
        1.2.5 Biologic therapies (biological drugs)
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Inflammatory Bowel Disease Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Inflammatory Bowel Disease Market Perspective (2017-2028)
    2.2 Inflammatory Bowel Disease Growth Trends by Region
        2.2.1 Inflammatory Bowel Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Inflammatory Bowel Disease Historic Market Size by Region (2017-2022)
        2.2.3 Inflammatory Bowel Disease Forecasted Market Size by Region (2023-2028)
    2.3 Inflammatory Bowel Disease Market Dynamics
        2.3.1 Inflammatory Bowel Disease Industry Trends
        2.3.2 Inflammatory Bowel Disease Market Drivers
        2.3.3 Inflammatory Bowel Disease Market Challenges
        2.3.4 Inflammatory Bowel Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Inflammatory Bowel Disease Players by Revenue
        3.1.1 Global Top Inflammatory Bowel Disease Players by Revenue (2017-2022)
        3.1.2 Global Inflammatory Bowel Disease Revenue Market Share by Players (2017-2022)
    3.2 Global Inflammatory Bowel Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Inflammatory Bowel Disease Revenue
    3.4 Global Inflammatory Bowel Disease Market Concentration Ratio
        3.4.1 Global Inflammatory Bowel Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Revenue in 2021
    3.5 Inflammatory Bowel Disease Key Players Head office and Area Served
    3.6 Key Players Inflammatory Bowel Disease Product Solution and Service
    3.7 Date of Enter into Inflammatory Bowel Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease Breakdown Data by Type
    4.1 Global Inflammatory Bowel Disease Historic Market Size by Type (2017-2022)
    4.2 Global Inflammatory Bowel Disease Forecasted Market Size by Type (2023-2028)
5 Inflammatory Bowel Disease Breakdown Data by Application
    5.1 Global Inflammatory Bowel Disease Historic Market Size by Application (2017-2022)
    5.2 Global Inflammatory Bowel Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Inflammatory Bowel Disease Market Size (2017-2028)
    6.2 North America Inflammatory Bowel Disease Market Size by Country (2017-2022)
    6.3 North America Inflammatory Bowel Disease Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Inflammatory Bowel Disease Market Size (2017-2028)
    7.2 Europe Inflammatory Bowel Disease Market Size by Country (2017-2022)
    7.3 Europe Inflammatory Bowel Disease Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Inflammatory Bowel Disease Market Size (2017-2028)
    8.2 Asia-Pacific Inflammatory Bowel Disease Market Size by Country (2017-2022)
    8.3 Asia-Pacific Inflammatory Bowel Disease Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Inflammatory Bowel Disease Market Size (2017-2028)
    9.2 Latin America Inflammatory Bowel Disease Market Size by Country (2017-2022)
    9.3 Latin America Inflammatory Bowel Disease Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Inflammatory Bowel Disease Market Size (2017-2028)
    10.2 Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2017-2022)
    10.3 Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bristol-Myers Squibb Company
        11.1.1 Bristol-Myers Squibb Company Company Detail
        11.1.2 Bristol-Myers Squibb Company Business Overview
        11.1.3 Bristol-Myers Squibb Company Inflammatory Bowel Disease Introduction
        11.1.4 Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.1.5 Bristol-Myers Squibb Company Recent Development
    11.2 Baxter International
        11.2.1 Baxter International Company Detail
        11.2.2 Baxter International Business Overview
        11.2.3 Baxter International Inflammatory Bowel Disease Introduction
        11.2.4 Baxter International Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.2.5 Baxter International Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Detail
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Inflammatory Bowel Disease Introduction
        11.3.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Development
    11.4 Sanofi-Aventis
        11.4.1 Sanofi-Aventis Company Detail
        11.4.2 Sanofi-Aventis Business Overview
        11.4.3 Sanofi-Aventis Inflammatory Bowel Disease Introduction
        11.4.4 Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.4.5 Sanofi-Aventis Recent Development
    11.5 Abbott Laboratories
        11.5.1 Abbott Laboratories Company Detail
        11.5.2 Abbott Laboratories Business Overview
        11.5.3 Abbott Laboratories Inflammatory Bowel Disease Introduction
        11.5.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.5.5 Abbott Laboratories Recent Development
    11.6 Pluristem Therapeutics
        11.6.1 Pluristem Therapeutics Company Detail
        11.6.2 Pluristem Therapeutics Business Overview
        11.6.3 Pluristem Therapeutics Inflammatory Bowel Disease Introduction
        11.6.4 Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.6.5 Pluristem Therapeutics Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Detail
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Inflammatory Bowel Disease Introduction
        11.7.4 Pfizer Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.7.5 Pfizer Recent Development
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Detail
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Inflammatory Bowel Disease Introduction
        11.8.4 AstraZeneca Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.8.5 AstraZeneca Recent Development
    11.9 Cephalon
        11.9.1 Cephalon Company Detail
        11.9.2 Cephalon Business Overview
        11.9.3 Cephalon Inflammatory Bowel Disease Introduction
        11.9.4 Cephalon Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.9.5 Cephalon Recent Development
    11.10 Amgen
        11.10.1 Amgen Company Detail
        11.10.2 Amgen Business Overview
        11.10.3 Amgen Inflammatory Bowel Disease Introduction
        11.10.4 Amgen Revenue in Inflammatory Bowel Disease Business (2017-2022)
        11.10.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Inflammatory Bowel Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Aminosalicylates
    Table 3. Key Players of Antibiotics
    Table 4. Key Players of Corticosteroids
    Table 5. Key Players of Biologic therapies (biological drugs)
    Table 6. Key Players of Others
    Table 7. Global Inflammatory Bowel Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Inflammatory Bowel Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Inflammatory Bowel Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Inflammatory Bowel Disease Market Share by Region (2017-2022)
    Table 11. Global Inflammatory Bowel Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Inflammatory Bowel Disease Market Share by Region (2023-2028)
    Table 13. Inflammatory Bowel Disease Market Trends
    Table 14. Inflammatory Bowel Disease Market Drivers
    Table 15. Inflammatory Bowel Disease Market Challenges
    Table 16. Inflammatory Bowel Disease Market Restraints
    Table 17. Global Inflammatory Bowel Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Inflammatory Bowel Disease Market Share by Players (2017-2022)
    Table 19. Global Top Inflammatory Bowel Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease as of 2021)
    Table 20. Ranking of Global Top Inflammatory Bowel Disease Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Inflammatory Bowel Disease Product Solution and Service
    Table 24. Date of Enter into Inflammatory Bowel Disease Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Inflammatory Bowel Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Inflammatory Bowel Disease Revenue Market Share by Type (2017-2022)
    Table 28. Global Inflammatory Bowel Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Inflammatory Bowel Disease Revenue Market Share by Type (2023-2028)
    Table 30. Global Inflammatory Bowel Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Inflammatory Bowel Disease Revenue Market Share by Application (2017-2022)
    Table 32. Global Inflammatory Bowel Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Inflammatory Bowel Disease Revenue Market Share by Application (2023-2028)
    Table 34. North America Inflammatory Bowel Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Inflammatory Bowel Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Inflammatory Bowel Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Inflammatory Bowel Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Inflammatory Bowel Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Inflammatory Bowel Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Bristol-Myers Squibb Company Company Detail
    Table 45. Bristol-Myers Squibb Company Business Overview
    Table 46. Bristol-Myers Squibb Company Inflammatory Bowel Disease Product
    Table 47. Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 48. Bristol-Myers Squibb Company Recent Development
    Table 49. Baxter International Company Detail
    Table 50. Baxter International Business Overview
    Table 51. Baxter International Inflammatory Bowel Disease Product
    Table 52. Baxter International Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 53. Baxter International Recent Development
    Table 54. Johnson & Johnson Company Detail
    Table 55. Johnson & Johnson Business Overview
    Table 56. Johnson & Johnson Inflammatory Bowel Disease Product
    Table 57. Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 58. Johnson & Johnson Recent Development
    Table 59. Sanofi-Aventis Company Detail
    Table 60. Sanofi-Aventis Business Overview
    Table 61. Sanofi-Aventis Inflammatory Bowel Disease Product
    Table 62. Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 63. Sanofi-Aventis Recent Development
    Table 64. Abbott Laboratories Company Detail
    Table 65. Abbott Laboratories Business Overview
    Table 66. Abbott Laboratories Inflammatory Bowel Disease Product
    Table 67. Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 68. Abbott Laboratories Recent Development
    Table 69. Pluristem Therapeutics Company Detail
    Table 70. Pluristem Therapeutics Business Overview
    Table 71. Pluristem Therapeutics Inflammatory Bowel Disease Product
    Table 72. Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 73. Pluristem Therapeutics Recent Development
    Table 74. Pfizer Company Detail
    Table 75. Pfizer Business Overview
    Table 76. Pfizer Inflammatory Bowel Disease Product
    Table 77. Pfizer Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 78. Pfizer Recent Development
    Table 79. AstraZeneca Company Detail
    Table 80. AstraZeneca Business Overview
    Table 81. AstraZeneca Inflammatory Bowel Disease Product
    Table 82. AstraZeneca Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 83. AstraZeneca Recent Development
    Table 84. Cephalon Company Detail
    Table 85. Cephalon Business Overview
    Table 86. Cephalon Inflammatory Bowel Disease Product
    Table 87. Cephalon Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 88. Cephalon Recent Development
    Table 89. Amgen Company Detail
    Table 90. Amgen Business Overview
    Table 91. Amgen Inflammatory Bowel Disease Product
    Table 92. Amgen Revenue in Inflammatory Bowel Disease Business (2017-2022) & (US$ Million)
    Table 93. Amgen Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Inflammatory Bowel Disease Market Share by Type: 2021 VS 2028
    Figure 2. Aminosalicylates Features
    Figure 3. Antibiotics Features
    Figure 4. Corticosteroids Features
    Figure 5. Biologic therapies (biological drugs) Features
    Figure 6. Others Features
    Figure 7. Global Inflammatory Bowel Disease Market Share by Application in 2021 & 2028
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Others Case Studies
    Figure 11. Inflammatory Bowel Disease Report Years Considered
    Figure 12. Global Inflammatory Bowel Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Inflammatory Bowel Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Inflammatory Bowel Disease Market Share by Region: 2021 VS 2028
    Figure 15. Global Inflammatory Bowel Disease Market Share by Players in 2021
    Figure 16. Global Top Inflammatory Bowel Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Revenue in 2021
    Figure 18. North America Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Inflammatory Bowel Disease Market Share by Country (2017-2028)
    Figure 20. United States Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Inflammatory Bowel Disease Market Share by Country (2017-2028)
    Figure 24. Germany Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Inflammatory Bowel Disease Market Share by Region (2017-2028)
    Figure 32. China Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Inflammatory Bowel Disease Market Share by Country (2017-2028)
    Figure 40. Mexico Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Inflammatory Bowel Disease Market Share by Country (2017-2028)
    Figure 44. Turkey Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Inflammatory Bowel Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Bristol-Myers Squibb Company Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 47. Baxter International Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 49. Sanofi-Aventis Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 50. Abbott Laboratories Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 51. Pluristem Therapeutics Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 52. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 53. AstraZeneca Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 54. Cephalon Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 55. Amgen Revenue Growth Rate in Inflammatory Bowel Disease Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol-Myers Squibb Company
Baxter International
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
Pluristem Therapeutics
Pfizer
AstraZeneca
Cephalon
Amgen
Frequently Asked Questions
Inflammatory Bowel Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inflammatory Bowel Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inflammatory Bowel Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Inflatable Toys

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

In-flight Broadband

In-flight Broadband market is segmented by players, region (country), by Type and by Application. ... Read More

In-Flight Catering

In-Flight Catering market is segmented by players, region (country), by Aircraft Seating Class an ... Read More